A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Mild to Moderate Atopic Dermatitis
Interventions
DEVICE

Zarzenda

Topical cream, applied twice daily for three weeks

DRUG

Elidel

1% cream, applied topically twice daily for three weeks

Trial Locations (1)

53105

Klinik und Poliklinik fuer Dermatologie, Universtitaetsklinikum, Bonn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY